Frazier Life Sciences Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $498M | Hold |
|
|||||
|
2025
Q2 | $346M | Hold |
|
|||||
|
2025
Q1 | $306M | Buy |
|
|||||
|
2024
Q4 | $272M | Hold |
|
|||||
|
2024
Q3 | $256M | Buy |
|
|||||
|
2024
Q2 | $222M | Hold |
|
|||||
|
2024
Q1 | $163M | Hold |
|
|||||
|
2023
Q4 | $192M | Buy |
|
|||||
|
2023
Q3 | $204M | Buy |
|
|||||
|
2023
Q2 | $113M | Buy |
|
|||||
|
2023
Q1 | $92.7M | Hold |
|
|||||
|
2022
Q4 | $75.3M | Buy |
|
|||||
|
2022
Q3 | $80.4M | Buy |
|
|||||
|
2022
Q2 | $69.4M | Hold |
|
|||||
|
2022
Q1 | $78.5M | Buy |
|